1 |
VERDIN E. NAD⁺ in aging, metabolism, and neurodegeneration[J]. Science, 2015, 350(6265): 1208-1213.
|
2 |
GRIFFITHS H B S, WILLIAMS C, KING S J, et al. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target[J]. Biochem Soc Trans, 2020, 48(3): 733-744.
|
3 |
ZAPATA-PÉREZ R, WANDERS R J A, VAN KARNEBEEK C D M, et al. NAD+ homeostasis in human health and disease[J]. EMBO Mol Med, 2021, 13(7): e13943.
|
4 |
FANG E F, LAUTRUP S, HOU Y J, et al. NAD+ in aging: molecular mechanisms and translational implications[J]. Trends Mol Med, 2017, 23(10): 899-916.
|
5 |
KISS T, BALASUBRAMANIAN P, VALCARCEL-ARES M N, et al. Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment[J]. GeroScience, 2019, 41(5): 619-630.
|
6 |
SONG J, LI J, YANG F J, et al. Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow[J]. Cell Death Dis, 2019, 10(5): 336.
|
7 |
BERTOLDO M J, LISTIJONO D R, HO W H J, et al. NAD+ repletion rescues female fertility during reproductive aging[J]. Cell Rep, 2020, 30(6): 1670-1681.e7.
|
8 |
KISS T, GILES C B, TARANTINI S, et al. Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects[J]. GeroScience, 2019, 41(4): 419-439.
|
9 |
YI M Q, MA Y Y, ZHU S B, et al. Comparative proteomic analysis identifies biomarkers for renal aging[J]. Aging, 2020, 12(21): 21890-21903.
|
10 |
CATON P W, KIESWICH J, YAQOOB M M, et al. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function[J]. Diabetologia, 2011, 54(12): 3083-3092.
|
11 |
YOSHINO J, MILLS K F, YOON M J, et al. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice[J]. Cell Metab, 2011, 14(4): 528-536.
|
12 |
MAJEED Y, HALABI N, MADANI A Y, et al. SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways[J]. Sci Rep, 2021, 11(1): 8177.
|
13 |
YOSHINO M, YOSHINO J, KAYSER B D, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women[J]. Science, 2021, 372(6547): 1224-1229.
|
14 |
钟琳, 王晓舜, 王婷婷, 等. 青娥方提取物对D-半乳糖致衰老小鼠的延缓衰老作用及机制[J]. 中国实验方剂学杂志, 2015, 21(16): 134-138.
|
15 |
朱亚珍, 朱虹光. D-半乳糖致衰老动物模型的建立及其检测方法[J]. 复旦学报(医学版), 2007, 34(4): 617-619.
|
16 |
SADIGH-ETEGHAD S, MAJDI A, MCCANN S K, et al. D-galactose-induced brain ageing model: a systematic review and meta-analysis on cognitive outcomes and oxidative stress indices[J]. PLoS One, 2017, 12(8): e0184122.
|
17 |
BRAIDY N, LIU Y. NAD+ therapy in age-related degenerative disorders: a benefit/risk analysis[J]. Exp Gerontol, 2020, 132: 110831.
|
18 |
HOSSEINI L, FAROKHI-SISAKHT F, BADALZADEH R, et al. Nicotinamide mononucleotide and melatonin alleviate aging-induced cognitive impairment via modulation of mitochondrial function and apoptosis in the prefrontal cortex and hippocampus[J]. Neuroscience, 2019, 423: 29-37.
|
19 |
WHITSON J A, BITTO A, ZHANG H, et al. SS-31 and NMN: two paths to improve metabolism and function in aged hearts [J]. Aging Cell, 2020, 19(10): e13213.
|
20 |
付媛, 张美莉, 高韶辉, 等. 裸燕麦球蛋白源多肽作用于D-半乳糖致衰老小鼠的代谢组学研究[J]. 食品科学, 2020, 41(17): 118-125.
|
21 |
和昱辰, 张波. 代谢组学技术及其在医学检验中的应用[J]. 国际检验医学杂志, 2014, 35(8): 1016-1018.
|
22 |
刘虎. 基于维持状态的生长猪能量需要和代谢组研究[D]. 北京: 中国农业大学, 2018.
|
23 |
BAI P, CANTÓ C, OUDART H, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation [J]. Cell Metab, 2011, 13(4): 461-468.
|
24 |
UDDIN G M, YOUNGSON N A, SINCLAIR D A, et al. Head to head comparison of short-term treatment with the NAD+ precursor nicotinamide mononucleotide (NMN) and 6 weeks of exercise in obese female mice[J]. Front Pharmacol, 2016, 7: 258.
|
25 |
TARRAGÓ M G, CHINI C C S, KANAMORI K S, et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline[J]. Cell Metab, 2018, 27(5): 1081-1095.
|
26 |
高璐, 王滢, 饶胜其, 等. 葡萄籽原花青素提取物对衰老模型小鼠抗氧化作用[J]. 食品科学, 2014, 35(23): 253-256.
|
27 |
郭怡琼, 吴琼, 吴雅婷, 等. 枸杞多糖和有氧运动对大鼠非酒精性脂肪肝的干预效果及其机制研究[J]. 上海交通大学学报(医学版), 2020, 40(1): 30-36.
|
28 |
KRATZ E M, SOŁKIEWICZ K, KUBIS-KUBIAK A, et al. Sirtuins as important factors in pathological states and the role of their molecular activity modulators[J]. Int J Mol Sci, 2021, 22(2): 630.
|
29 |
GOMES A P, PRICE N L, LING A J, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging[J]. Cell, 2013, 155(7): 1624-1638.
|